XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements Of Income - USD ($)
shares in Thousands, $ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues        
Total Revenues $ 1,537.6 $ 1,584.4 $ 4,871.9 $ 4,604.8
Expenses        
Compensation and benefits 237.6 218.8 665.9 629.5
Technology 71.4 66.6 208.0 190.1
Professional fees and outside services 36.7 31.0 102.6 98.8
Amortization of purchased intangibles 56.2 55.7 167.5 166.4
Depreciation and amortization 26.4 28.2 81.0 87.0
Licensing and other fee agreements 81.6 97.6 274.4 271.4
Other 55.1 62.3 162.6 177.2
Total Expenses 565.0 560.2 1,662.0 1,620.4
Operating Income 972.6 1,024.2 3,209.9 2,984.4
Non-Operating Income (Expense)        
Investment income 1,548.7 1,026.8 3,959.8 3,142.6
Interest and other borrowing costs (44.0) (40.2) (129.7) (120.2)
Equity in net earnings of unconsolidated subsidiaries 96.3 86.1 283.5 259.7
Other non-operating income (expense) (1,396.6) (920.0) (3,571.4) (2,821.7)
Total Non-Operating Income (Expense) 204.4 152.7 542.2 460.4
Income before Income Taxes 1,177.0 1,176.9 3,752.1 3,444.8
Income tax provision 269.0 264.1 862.8 793.6
Net Income 908.0 912.8 2,889.3 2,651.2
Net Income Attributable to Common Shareholders of CME Group $ 896.6 $ 901.3 $ 2,853.0 $ 2,617.8
Earnings per Share Attributable to Common Shareholders of CME Group:        
Basic (in dollars per share) $ 2.49 $ 2.51 $ 7.93 $ 7.29
Diluted (in dollars per share) $ 2.49 $ 2.50 $ 7.92 $ 7.27
Weighted Average Number of Common Shares:        
Basic (in shares) 359,686 359,400 359,653 359,329
Diluted (in shares) 360,422 359,989 360,330 359,899
Clearing and transaction fees [Member]        
Revenues        
Total Revenues $ 1,227.9 $ 1,297.1 $ 3,953.2 $ 3,755.9
Market data and information services        
Revenues        
Total Revenues 202.5 178.2 595.1 528.6
Other        
Revenues        
Total Revenues $ 107.2 $ 109.1 $ 323.6 $ 320.3